Ayass BioScience, LLC
Trivendra Tripathi is an experienced professional in the field of immunology and molecular biology, currently serving as Director of the Flow Cytometry Core and Scientist in Flow Cytometry at Ayass BioScience, LLC, where expertise in IVD assay development and strategic leadership in clinical and R&D Flow Cytometry is provided. In addition, Trivendra holds the position of Marketing & Business Senior Associate at Ayass Research Institute's F420 Program. Previous roles include Scientist at Abexxa Biologics, overseeing laboratory operations and developing Immuno-Oncology assays, and Senior Research Fellow at Mayo Clinic, where lab management and development of SOPs for various research proposals were key responsibilities. Trivendra also has extensive experience as a Postdoctoral Research Associate at Baylor Scott & White Health and the University of North Texas Health Science Center, focusing on lab operations and developing in vivo models. Trivendra earned a Ph.D. in Biochemistry from Aligarh Muslim University and holds a Master's degree in Biotechnology from Kanpur University.
This person is not in any teams
Ayass BioScience, LLC
Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcome by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, and next generation sequencing. Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. Our goal is to help clinicians implement unique precision medicine in their daily practice. Ayass BioScience, LLC (DBA as Ayass Lung Clinic, PLLC) is a CLIA certified laboratory performing advanced Next Generation Sequencing (Genetic Testing), Cardiac Conditions Hereditary Risk Assessment, Hereditary Cancer Risk Assessment, Neurological Conditions Genetic Predisposition Testing, also COVID-19 Testing (COVID-19 SARS-CoV-2 by RT-PCR), Pharmacogenetic Testing, Allergen Component-Resolved Testing, and Innovative Laboratory Testing. Ayass BioiScience, LLC is working on Aptamers Research and Testing. Ayass BioScience, LLC aims to be at the forefront of latest advancements in precision medicine to provide you with the most effective prevention and treatment options possible.